Study | Year | Numbers of patients (HCR/CABG) | Study design | CABG | HCR strategy | Follow-up (months) |
---|---|---|---|---|---|---|
Kon [17] | 2007 | 15/30 | Non-RCT | OPCABG | Simultaneous | 12 |
Zhao [11] | 2008 | 112/254 | Non-RCT | On-pump | Simultaneous | NR |
Reicher [14] | 2007 | 13/26 | Non-RCT | OPCABG | Simultaneous | 14 |
Vassiliades [12] | 2009 | 91/4175 | Non-RCT | OPCABG | PCI then MICABG | 12 |
6.6% | ||||||
MICABG then PCI | ||||||
93.4% | ||||||
Delhaye [20] | 2010 | 18/18 | Non-RCT | On-pump | CABG then PCI | 12 |
OPCABG then PCI | ||||||
Hu [18] | 2010 | 104/104 | Non-RCT | OPCABG | Simultaneous | 18 ± 7.9 |
Halkos [19] | 2011 | 147/588 | Non-RCT | OPCABG | Mainly staged | 38.4 (median) |
Bachinsky [21] | 2012 | 25/27 | Non-RCT | OPCABG | Simultaneous | 1 |
Leacche [16] | 2012 | 80/301 | Non-RCT | OPCABG | NR | 1 |
Popov [15] | Unpublished | 18/30 | RCT | On-pump | MICABG then PCI | 1 |